Overview / Abstract: |
Hear from Christian Ruff, MD, MPH on the latest clinical trial data related to DOACs and implications for patient care. This expert perspective provides clinicians with practical insights to apply to their practice. Dr. Ruff discusses the most recent evidence with DOACs across a multitude of disease states, including acute venous thromboembolism in patients with elevated BMI, peripheral artery disease, and COVID-19. Exciting new evidence with the novel factor XIa drug class is also covered. |
Expiration |
Dec 17, 2022 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
.50 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Christian T. Ruff, MD, MPH |
Activity Specialities / Related Topics |
Cardiology / Cardiovascular, Primary Care |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Janssen Scientific Affairs, LLC. |
Keywords / Search Terms |
ACHL CME, CME/CE, Janssen, Christian Ruff, AHA, VKA, PAD, DOAC, VTE, BMI, EHR, rivaroxaban, apixaban, dabigatran, anticoagulant, warfarin, CV, limb outcomes, Ischemic, stroke, CVA, obese, prophylaxis, factor Xa inhibitor, SARS CoV-2 Infection, Coagulopathy, enoxaparin, bleeding event, Thrombus Free CE CME |